- Home
- SIF vs CGTX Comparison
SIF vs CGTX Comparison
Compare SIF & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- CGTX
- Stock Information
- Founded
- SIF 1913
- CGTX 2007
- Country
- SIF United States
- CGTX United States
- Employees
- SIF N/A
- CGTX N/A
- Industry
- SIF Office Equipment/Supplies/Services
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- SIF Industrials
- CGTX Health Care
- Exchange
- SIF Nasdaq
- CGTX Nasdaq
- Market Cap
- SIF 18.6M
- CGTX 20.5M
- IPO Year
- SIF N/A
- CGTX 2021
- Fundamental
- Price
- SIF $3.56
- CGTX $0.26
- Analyst Decision
- SIF
- CGTX Strong Buy
- Analyst Count
- SIF 0
- CGTX 5
- Target Price
- SIF N/A
- CGTX $5.63
- AVG Volume (30 Days)
- SIF 15.1K
- CGTX 1.8M
- Earning Date
- SIF 08-11-2025
- CGTX 08-07-2025
- Dividend Yield
- SIF N/A
- CGTX N/A
- EPS Growth
- SIF N/A
- CGTX N/A
- EPS
- SIF N/A
- CGTX N/A
- Revenue
- SIF $83,554,000.00
- CGTX N/A
- Revenue This Year
- SIF N/A
- CGTX N/A
- Revenue Next Year
- SIF N/A
- CGTX N/A
- P/E Ratio
- SIF N/A
- CGTX N/A
- Revenue Growth
- SIF 35.83
- CGTX N/A
- 52 Week Low
- SIF $2.33
- CGTX $0.22
- 52 Week High
- SIF $5.96
- CGTX $2.54
- Technical
- Relative Strength Index (RSI)
- SIF 57.31
- CGTX 37.68
- Support Level
- SIF $3.55
- CGTX $0.29
- Resistance Level
- SIF $4.14
- CGTX $0.32
- Average True Range (ATR)
- SIF 0.25
- CGTX 0.03
- MACD
- SIF -0.01
- CGTX 0.00
- Stochastic Oscillator
- SIF 38.30
- CGTX 12.50
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.